Venus Remedies Limited - Asset Resilience Ratio

Latest as of September 2025: 30.75%

Venus Remedies Limited (VENUSREM) has an Asset Resilience Ratio of 30.75% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See VENUSREM working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs2.36 Billion
≈ $25.54 Million USD Cash + Short-term Investments

Total Assets

Rs7.68 Billion
≈ $83.07 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how Venus Remedies Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see VENUSREM total assets.

Liquid Assets Composition Over Time

This chart breaks down Venus Remedies Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Venus Remedies Limited (VENUSREM) long-term investment share to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs219.90 Million 2.86%
Short-term Investments Rs2.14 Billion 27.89%
Total Liquid Assets Rs2.36 Billion 30.75%

Asset Resilience Insights

  • Very High Liquidity: Venus Remedies Limited maintains exceptional liquid asset reserves at 30.75% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Venus Remedies Limited Industry Peers by Asset Resilience Ratio

Compare Venus Remedies Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Yunnan Baiyao Group Co Ltd
SHE:000538
Drug Manufacturers - Specialty & Generic 8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
Drug Manufacturers - Specialty & Generic 6.62%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Harbin Gloria Pharmaceuticals
SHE:002437
Drug Manufacturers - Specialty & Generic 9.04%
Jiuzhitang Co Ltd
SHE:000989
Drug Manufacturers - Specialty & Generic 7.86%
Renhe Pharmacy Co Ltd
SHE:000650
Drug Manufacturers - Specialty & Generic 37.54%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%

Annual Asset Resilience Ratio for Venus Remedies Limited (2006–2025)

The table below shows the annual Asset Resilience Ratio data for Venus Remedies Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 21.84% Rs1.56 Billion
≈ $16.90 Million
Rs7.16 Billion
≈ $77.40 Million
+8.47pp
2024-03-31 13.37% Rs838.05 Million
≈ $9.06 Million
Rs6.27 Billion
≈ $67.79 Million
+1.38pp
2023-03-31 11.99% Rs720.75 Million
≈ $7.79 Million
Rs6.01 Billion
≈ $65.00 Million
+4.18pp
2022-03-31 7.81% Rs453.11 Million
≈ $4.90 Million
Rs5.80 Billion
≈ $62.71 Million
+2.55pp
2021-03-31 5.26% Rs292.55 Million
≈ $3.16 Million
Rs5.56 Billion
≈ $60.11 Million
+4.94pp
2020-03-31 0.32% Rs20.42 Million
≈ $220.88K
Rs6.38 Billion
≈ $68.97 Million
+0.01pp
2019-03-31 0.31% Rs23.01 Million
≈ $248.80K
Rs7.33 Billion
≈ $79.25 Million
-0.65pp
2018-03-31 0.96% Rs72.21 Million
≈ $780.93K
Rs7.51 Billion
≈ $81.20 Million
-7.66pp
2017-03-31 8.63% Rs715.21 Million
≈ $7.73 Million
Rs8.29 Billion
≈ $89.67 Million
+8.30pp
2006-03-31 0.33% Rs2.04 Million
≈ $22.07K
Rs622.28 Million
≈ $6.73 Million
--
pp = percentage points

About Venus Remedies Limited

NSE:VENUSREM India Drug Manufacturers - Specialty & Generic
Market Cap
$228.72 Million
Rs21.15 Billion INR
Market Cap Rank
#16124 Global
#823 in India
Share Price
Rs1582.20
Change (1 day)
+2.09%
52-Week Range
Rs432.30 - Rs1947.00
All Time High
Rs1947.00
About

Venus Remedies Limited engages in the pharmaceutical business in India and internationally. It is involved in the research and development of solutions focusing on antimicrobial resistance and oncology. The company also offers analgesic, analgesic and antipyretic, antibiotic, anticoagulant, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormo… Read more